Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$15.25
Change (%)0.00 (0.00%)
Volume0
Data as of 08/17/17 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
08/09/17
Download Documentation Corporate Update August 2017

Recent News

More >>
DateTitle 
08/09/17Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate ProgressPrinter Friendly Version
08/09/17Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDAPrinter Friendly Version
05/30/17Heron Therapeutics to Present at the Jefferies 2017 Healthcare ConferencePrinter Friendly Version
05/10/17Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate ProgressPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.